Serum levels of IL-6 and CRP can predict the efficacy of mFOLFIRINOX in patients with advanced pancreatic cancer

Overview of attention for article published in Frontiers in oncology, July 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 1 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 906 followers.

New article: Serum levels of IL-6 and CRP can predict the efficacy of mFOLFIRINOX in patients with advanced pancreatic cancer https://t.co/yzFdsXzB1t #pancreaticcancer #oncology https://t.co/IBSHFMMR7p

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.